Preliminary Program
Thursday, 26 March, 2015
14:00
Registration
18:30
Welcome Reception
Friday, 27 March, 2015
08:45 - 09:00 Opening Ceremony
Greetings by:
Hermann Haller, Germany, Conference Co-Chair
Giuseppe Mancia, Italy, Conference Co-Chair
Talma Rosenthal, Israel, Conference Co-Chair
09:00 -10:30 Plenary Session 1
09:00
Fixed Dose Combinations and Guidelines (Invited Lecture)
G. Mancia, University of Milano-Bicocca, Milano, Italy
09:30
Targeting the Endothelium – Strategies in Combination Therapy
(Invited Lecture)
H. Haller, Dept. of Nephrology, Hannover Medical School, Hannover, Germany
10:00
Antihypertensive Drug Selection Based Upon Volume and
Vasoconstriction (Invited Lecture)
M. Alderman, Albert Einstein College of Medicine, Bronx, NY, USA
10:30 - 11:00 Coffee Break, Exhibition Visit and Posters Viewing
11:00 - 13:00 Plenary Session 2
11:00
Combination Therapy in Hypertension: What is Suggested by
Randomized Controlled Trials? (Invited Lecture)
A. Zanchetti, Istituto Auxologico Italiano and University of Milan, Italy
11:30
Early Combination Therapy in Type 2 Diabetes (Invited Lecture)
S. Del Prato, Department of Clinical and Experimental Medicine, University of
Pisa, Italy
12:00
Fixed Combination: Innovation that Stood the Test of Time
(Invited Lecture)
T. Rosenthal, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
12:30
Primary Hyperaldosteronism: Is the Epidemic Over? (Invited Lecture)
N. Stern, Tel Aviv Sourasky Medical Center, Israel
13:00 - 14:00 Lunch Break, Exhibition Visit and Posters Viewing
Friday, 27 March, 2015 (cont.)
14:00 - 15:30
Plenary Session 3: Free Paper Session
14:00
An Audit of Diabetes Self-Management Education Programs in South
Africa
L. Dube, Université Catholique de Louvain, Louvain, Belgium
14:15
Hormonal Contraception Related with Diabetes Mellitus Type 2
S. Lindawati, Health Department, Community Health Center, Jakarta,
Indonesia
14:30
Antidiabetic and Cardiovascular Properties of the Aqueous Extract from
the Stem Bark of Ceiba Pentandra on Dexamethasone-Induced Insulin
Resistant Rats
T.B. Nguelefack, Dept. of Animal Biology, Laboratory of Animal Physiology and
Phytopharmacology, Dschang, Cameroon
15:00
The Profile of Patients with Metabolic Syndrome on Fixed Dose
Combination Drugs
V.O. Palmeiri, Biomedical Sciences and Human Oncology, Clinica Medica "A.
Murri", Italy
15:15
Combination Phyto-Metformin Therapy to Diabetes and Related
Complications
K. Raafat, Pharmaceutical Sciences, Beirut Arab University, Lebanon
15:30 - 16:00 Coffee Break, Exhibition Visit and Posters Viewing
16:00 -17:00 Plenary Session 4: Free Paper Session
16:00
Combination Therapy in Lipid Disorders Patients: Past, Present and
Future (Invited Lecture)
M. Banach, Medical University of Lodz, Lodz, Poland
16:30
Napping: Is it Bad for you? (Invited Lecture)
M. Bursztyn, Department of Medicine, Hypertension Unit, Hadassah-Hebrew
University Medical Center, Mount-Scopus, Jerusalem, Israel
Saturday, 28 March, 2015
09:00 - 10:30 Plenary Session 5
09:00
Hypertension and Atrial Fibrillation (Invited Lecture)
A.J. Manolis, Asklepeion General Hospital, Athens, Greece
10:00
What is New in the Management of Blood Pressure in Chronic
Kidney Disease? (Invited Lecture)
E. Holtzman, The Chaim Sheba Medical Center, Tel Hashomer, Israel
10:30 - 11:00 Coffee Break, Exhibition Visit and Posters Viewing
10:30 - 12:30 Plenary Session 6: Free Papers
10:30
Dermcidin Isoform-2, An Inhibitor of Nitric Oxide Syntheses,
Abolishes the Effect of Acetyl Salicylic Acid in Platelet Aggregation
in Acute Myocardial Infarction
S. Bank, Sinha Institute of Medical Science & Technology, Kolkata, West
Bengal, India
10:45
The Activation by Glucose of Liver Membrane Nitric Oxide Synthase
in the Synthesis and Translocation of Glut-4 in the Production of
Insulin in the Mice Hepatocytes
S. Bhattacharya, Sinha Institute of Medical Science & Technology,
Kolkata, Non-USA, India
11:00
Central Administration of DHA and DHAderivative Regulates
Peripheral Energy Homeostasis by Increasing Central Leptin
Sensitivity in Mice
L. Cheng, School of Medicine, University of Wollongong, Wollongong,
NSW, Australia
11:15
Chronic Fatigue Syndrome vs Depressive Disease: Blood Pressure
is The Key - Midodrine and Sertraline Solution?
J.A. Meireles-Brandão, Medicina, Faculdade de Medicina do Porto and
Starmedica.Clinica, Porto, Portugal
11:30
Blood Pressure, Heart Rate, or the Rate Pressure Product: What is
the Best Predictor of Outcome in Arterial Hypertension?
K. Stoschitzky, Abteilung für Kardiologie, Medizinische Universitätsklinik
Graz, Graz, Austria
11:45
Evaluation of Serum Lipoproteins in Healthy Subjects, after Cultured
Shrimp (Litopenaeus Vananami) Consumption
F. Yousefi, The Persian Gulf Tropical Medicine Research Center,
Boushehr University of Medical Sciences, Iran
12:00
Management Practices in Hypertension: Results of WIN-OVER-A Pan
India Registry
A.Trailokya
12:15
High Dose of Fixed Combination of Olmesartan Plus Amlodipine
Allows a Good Compliance in Diabetics Receiving Multiple Drugs
V. Spagnuolo, Unit of Internal Medicine, Annunziata Hospital, Italy
12:30
The Fixed Combination in the Antihypertensive Treatment in Patients
after Renal Transplantation
Z. Heleniak, Dept. of Nephrology, Transplantology and Internal Medicine
Medical University of Gdańsk, Poland
13:00 – 14:00 Lunch Break, Exhibition Visit and Posters Viewing
Saturday, 28 March, 2015 (cont.)
14:00 - 16:00 Plenary Session 7
14:00
Combined Interference with the RAS in Cardiometabolic Disease:
AT1 Receptor Blockade and AT2 Receptor Stimulation in One Pill?
(Invited Lecture)
T. Unger, CARIM – School for Cardiovascular Diseases, Maastricht University,
The Netherlands
14:30
Arterial Destiffening: The Role of Combination Therapy (Invited Lecture)
R. Zimlichman, Sackler Faculty of Medicine, Tel-Aviv University,
The E. Wolfson Medical Center, Holon, Israel
15:00
Fixed Combination Treatment for Glycaemic Control in Type 2 Diabetes:
What is the Difference? (Invited Lecture)
P.M. Nilsson, Dept. of Clinical Sciences, Lund University, Sweden
15:30
Coffee Break, Exhibition Visit
16:00
Late Onset of Gingival Hyperplasia in a Patient Undergoing Fixed-Dose
Combination Antihypertensive Therapy
C. Podoleanu, Dept. of Cardiology, University of Medicine and Pharmacy of
Tirgu Mures, Romania
16:15
Origanum Majoranum Modulates Gene Expression, Hepatic and Renal
Changes in a Rat Model of Type 2 Diabetes
M. Nassan, Medical Laboratories, Taif University, Saudi Arabia, Egypt
16:30
Antihypercholesterolemic Effects of Mushroom, Chrysin, Curcumin and
Omega-3 in Experimental Hypercholesterolemic Rats
T. Ismail, Medical Laboratories, Taif University, Saudi Arabia, Egypt
16:45
Adjourn
Sunday, 29 March, 2015
09:00 - 10:30 Plenary Session 8
09:00
Vascular Health as a Focus in the Treatment of Hypertension
(Invited Lecture)
R. Touyz, University of Glasgow, UK
09:30
Fixed Combination in Management of Hypertensive Patients with
Diabetes (Invited Lecture)
K. Narkiewicz, Dept. of Hypertension and Diabetology, Medical University of
Gdansk, Poland
10:00
Adherence to Therapy – The Privotal Challenge in Hypertension
Treatment (Invited Lecture)
R.E. Schmieder, Medizinische Klinik, University Erlangen-Nuernberg, Germany
10:30 -11:00 Coffee Break, Exhibition Visit and Posters Viewing
11:00 - 13:15 Plenary Session 9
11:00
Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin
Fixed Dose Combination Compared to Separate Tablets
C. Lippert, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
11:30
Pros and Cons on Polypil
12:00
Management Practices in Hypertension: Results of WIN-OVER-A Pan
India Registry
A. Trailokya
12:15
Complementary Mechanisms of Action of Dapagliflozin and Metformin
A. Romanovschi, Global Medical Affairs, AstraZeneca, UK
12:30
Use of FDC in Initial Antihypertensive Therapy in Bulgaria
D. Raev, Clinic of Internal Medicine, University Hospital "St. Anna", Bulgaria
12:45
Investigation of Brain-Derived Neurotrophic Factor (BDNF) Gene
Expression in Hypothalamus of Obese Rats: Modulation by Omega-3
Fatty Acids
S. Abdel-Maksoud, German University in Cairo, Faculty of Pharmacy and
Biotechnology, Egypt
13:00
Higher Survival in Hypertension Patients on Fixed Drug Combination
Therapies
O. Odunukan, Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL, USA
POSTER PRESENTATIONS
The Health Benefit of Consuming a Cinnamon Supplement for 8 Weeks in Overweight
Women
T.S. Aldayel, Dept. of Nutritional Sciences, School of Biosciences and Medicine, Faculty of
Health and Medical Sciences,University of Surrey, UK
Formulation and Evuluation of Bilayer Tablet of Aotvastatin and Pioglitazone for
Metabolic Disorder
S.H. Ali, Pharmaceutics, Deccan School of Pharmacy, India
Influence of Kaempferol, a Flavonoid Compound, on Membrane-Bound Atpases in
Streptozotocin-Induced Diabetic Rats
K.S. Al-Numair, Community Health Sciences, College of Applied Medical Sciences, King
Saud University, Riyadh, Saudi Arabia
Endogenous Angiotensin-(1-7)/MAS Receptor/NO and Downstream Modulation of TNF:
Are Involved Cardioprotective Effects of Pacing Postconditioning
Fawzi Babiker, Physiology, Kuwait University, Kuwait
Significant Correlation of ET-1 Biomarker and Renal Endothelial Dysfunction, Real
Option for Efficient HTA Treatment in Diabetic Type 2 Patients
Benereta Hoxha, Dept. of Nephrology, Central Polyclinic, Albania
Young Patient Know Hypertensive for the Last 1 year should GP Investigated Her
Hypertension Earlier to Miss Her Diagnosis of Malignant Pheochromocytoma
F. Butt, General Medicine, Tan Tock Seng Hospital, Singapore
Eccentric Remodeling and Systolic Dysfunction Correction in Renal Hypertensive
Patients
N. Demikhova, Family Medicine, Sumy State Universuty, Sumy, Sumy, Ukraine
Effect of Alfa-Lipoic Acid on Hemostasis Parameters in Patients with Type I Diabetes
Mellitus
J. Kayumov, Endocrinology, Tashkent Medical Academy, Uzbekistan
Combined Supplementation with Quercetin and Myricetin Ameliorates Hyperglycemia
and Inflammation in Mice Fed a High-Fat, High-Sucrose Diet
J-I. Kim, Smart Food and Drugs, Inje University, Gimhae, Gyungnam, South Korea
The Possible Cardiovascular Effect of Medic SheosTM on Subjective and
Hemodynamic Parameters in Diabetic and/or PVD Patients
E. Klainman, Pulmonary Institute, Kaplan MC, Physiological Unit, Rehovot, Israel
Diastolic Function in Obese Hypertensive Patients using Different Fixed Combination
with ACE Inhibitor and Antagonist Calcium
Olga Korneeva, Cardiology, I.M. Sechenov First Moscow State Medical University, Russia
Arterial Stiffness Parameters in Obese Hypertensive Patients Using Different StatinBased Regimens and Fixed Antihypertensive Combination
Olga Korneeva, Cardiology, I.M. Sechenov First Moscow State Medical University, Russia
Impact of Lifestyle on CVD Risk Factors in the Young Adults
M. Koziarska-Rosciszewska, Nephrology, Hypertension and Family Medicine, Medical
University of Lodz, Poland
Non-Invasive Diagnosis of the Stages at Non-Alcoholic Fatty Liver Disease in Type 2
Diabetics by Determining of Oxidative Stress Intensity
N. Kravchun, Dept. of Clinical Endocrinology, State Institution ”V. Danilevsky Institute for
endocrine pathology problems National Academy of Medical sciences of Ukraine”, Kharkov,
Ukraine
Comparison of Lipid Lowering Effects between Ezetimibe and Pravastatin: Results
from a Pilot Crossover Study
N. Kume, Division of Clinical Pharmacy, Kobe Gakuin University, Kobe, Japan
Features Fixed Combination in Management of Hypertensive Patients with Diabetes,
Dyslipidemia and Subclinical Hypothyroidism
Alla Logvinenko, Dept. of Essential Hypertension, National Scientific Center “M.D.
Strazhesko Institute of Cardiology of NAMS of Ukraine”, Ukraine
Atherogenic Potential and Insulin Resistance of Subclinical Hypothyroidism and Ways
of His Correction
Alla Logvinenko, Dept. of Essential Hypertension, National Scientific Center “M.D.
Strazhesko Institute of Cardiology of NAMS of Ukraine”, Ukraine
Analytical Methods for Quantitative Determination of Fixed Dose Combinations with
Selective Beta-Blockers in Biological Fluids
S.C. Mahu, Dept. of Toxicology, Faculty of Pharmacy, University of Medicine and Pharmacy
"Grigore T. Popa"- Iași, Romania
Left Ventricular Diastolic Dysfunction & Cardiovascular Autonomic Neuropathy in Type
2 Diabetes Mellitus – A Cross Sectional Clinical Study
S. Mythri, Internal Medicine, Rajiv Gandhi University of Health Sciences, Bangalore, India
Fixed Combination Sitagliptine-Met Formin (Janumet®) in the Treatment of Type 2
Diabetic Patients with High Cardiovascular Risk
S. Nedogoda, Dept. of Therapy and Endocrinology FUV, Volgograd State Medical University,
Russia
Fixed Combination Vildagliptine-Me-Formin (Galvusmet®) in the Treatment of
Overweight Patients with Metabolic Syndrome
S. Nedogoda, Department of Therapy and Endocrinology FUV, Volgograd State Medical
University, Russia
Estimation of Application of Fixed Combinations: Angiotensin Receptor II Antagonists:
Calcium Channel Blockers for Hypertension Treatment
D. Obreshkova, Dept. of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University
Sofia, Bulgaria
Cardio Metabolic Risk factors in Spinal Cord Injured People
Z. Soltani, Teran University Medical Science, Brain & Spinal Injury Research Centre, Iran
Assessment of the Impact of Hypolipidemic Therapy on the relationship between Lipid
Parameters and Inflammatory Markers in Non-Diabetic Obese Patients
M. Stępień, Dept. of Nephrology, Hypertension and Family Medicine, Medical University of
Lodz, Poland
Efficiency of Fixed Combination Amlodipine and Lisinopril in the Treatment of Stable
Coronary Artery Disease and Hypertension
V. Sujayeva, Laboratory of Cardiac Rehabilitation, Republican Scientific and Practical Centre
"Cardiology", Minsk, Belarus
A Case of Diabetes who Experienced Cross-Sensitization of Skin Complication
between Lpragliflozin and Dapagliflozin
Y.Suzuki, Diabetes Department, HDC Atlas Clinic, Tokyo, Japan
The First Case of Type 2 Diabetes who Received SGLT2 Inhibitor Therapy after Kidney
Transplantation
Y.Suzuki, Diabetes Department, HDC Atlas Clinic, Tokyo, Japan
A Case of Type 2 Diabetes who Improved Carpal Tunnel Syndrome after Taking SGLT2
Inhibitors
Y.Suzuki, Diabetes Department, HDC Atlas Clinic, Tokyo, Japan
A Case of Diabetes who Experienced Improvement of Skin Complication after the
Change from Luseogliflozin to Dapagliflozin
Y.Suzuki, Diabetes Department, HDC Atlas Clinic, Tokyo, Japan
Compensatory Overeating (COE) could be a Problem of Diabetes Diet Education after
Sodium-Glucose Co-Transporter 2 Inhibitor Treatment
Y.Suzuki, Diabetes Department, HDC Atlas Clinic, Tokyo, Japan
Gain of Muscle Strength in Mitochondrial Diabetes Treated with SGLT2 Inhibitor
Y.Suzuki, Diabetes Department, HDC Atlas Clinic, Tokyo, Japan
Comparison of Monthly out of Pocket Costs between Fixed and Additive Combination
Therapies for Diabetes Mellitus and Dyslipidemia used in Turkey
H.S. Ulusoy, Pharmacology, Erciyes University Faculty of Medicine, Turkey
Attitude of the Doctors to Combined Pharmacotherapy of Hypertension in West
Belarus
V. Vdovichenko, Pharmacology, Medical University, Grodno, Belarus
Urinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity in
Adolescents with Primary Hypertension
A. Wasilewska, Dept. of Pediatrics and Nephrology, Medical University of Białystok, Poland
Prevalence of Metabolic Syndrome in Obese Type 2 Diabetic Subjects by using IDF and
NCEP-ATP III Definitions
M. Zeeshan, Allied Health Sciences, Ziauddin University, Karachi, Sindh, Pakistan
Assessment of Effect Vaccinium on Blood Pressure and Fasting Blood Sugar
F. Zolfaghari, Islamic Azad University, Arak Branch, Farzaneh, Iran